By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development and commercialization of therapeutic and diagnostic products that service women’s2.29M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.1.39M60.77%
International899.76K39.23%